4861-79-4 Usage
Description
Magnesium Methyl Carbonate is a chemical compound with the formula Mg(OH)(OCH3)COO. It is an organic magnesium salt that is soluble in water and has a white crystalline appearance. MAGNESIUM METHYL CARBONATE is known for its unique properties, such as its ability to act as a base and a mild antiseptic.
Uses
Used in Pharmaceutical Industry:
Magnesium Methyl Carbonate is used as a starting material for the synthesis of various pharmaceutical compounds, specifically oleanane and ursane triterpenoids. These triterpenoids are known for their active inhibition of nitric oxide production in mouse macrophages, which can be beneficial in the development of treatments for inflammatory diseases and conditions.
Used in Chemical Synthesis:
In the field of chemical synthesis, Magnesium Methyl Carbonate serves as a versatile reagent for the preparation of a wide range of organic compounds. Its ability to act as a base and a mild antiseptic makes it a valuable component in the synthesis of various pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Research and Development:
Magnesium Methyl Carbonate is also utilized in research and development laboratories for the study of its properties and potential applications. Its unique characteristics make it an interesting subject for scientific investigation, which could lead to the discovery of new uses and applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 4861-79-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,8,6 and 1 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 4861-79:
(6*4)+(5*8)+(4*6)+(3*1)+(2*7)+(1*9)=114
114 % 10 = 4
So 4861-79-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO3/c1-11-6-9(13)7-3-4-8(12)10(5-7)14-2/h3-5,9,11-13H,6H2,1-2H3/t9-/m0/s1
4861-79-4Relevant articles and documents
BIOSYNTHESIS OF CANNABINOID PRODRUGS AND THEIR USE AS THERAPEUTIC AGENTS
-
Paragraph 0200, (2017/11/07)
The present invention provides methods for producing cannabinoid prodrugs. Also described are pharmaceuticals acceptable compositions of the prodrugs and a system for the large-scale production of the prodrugs.
BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS
-
Paragraph 0134; 0135; 0136, (2017/10/18)
The present invention provides methods for producing cannabinoids. More specifically, the invention is directed to the bio-enzymatic synthesis of THC-v, CBV and CBN by contacting a compound according to Formula I with a cannabinoid synthase enzyme. Also described is a system for producing these pharmaceutically important cannabinoids and the use of such cannabinoids as therapeutic agents.
BIOSYNTHESIS OF CANNABINOIDS
-
Paragraph 0127-0129, (2014/09/16)
The present invention provides methods for producing cannabinoids and cannabinoid analogs as well as a system for producing these compounds. The inventive method is directed to contacting a compound according to Formula I or Formula II with a cannabinoid synthase. Also described is a system for producing cannabinoids and cannabinoid analogs by contacting a THCA synthase with a cannabinoid precursor and modifying at least one property of the reaction mixture to influence the quantity formed of a first cannabinoid relative to the quantity formed of a second cannabinoid.
